Bifodan Develops Formulation of Clinically Documented Probiotic Strains
04 May 2015 --- Bifodan A/S, a distinct partner in probiotic finished solutions for the private label industry, announces the market introduction of FastMelt Immuno at Vitafoods in Geneva. FastMelt Immuno is a formulation of clinically documented probiotic strains and an innovative matrix of carefully selected excipients, offering the consumer a uniquely convenient, efficacious and fun solution in support of year-round immune health.
A novel and efficacious formulation, FastMelt Immuno is introduced into an almost 3 billion dollar growing market, with an untapped demand for truly efficacious immune health products, backed by strong science: 88% of consumers are interested in buying products supporting immune health, but only 40% are actually purchasing the products according to recent market research. FastMelt Immuno is a probiotic powder designed for direct dosing on the tongue. The powder has been especially developed for a fast melting, cooling and well tasting experience.
“The probiotic solution offered in FastMelt Immuno is based on our extensive experience in selecting thoroughly documented probiotic strains for all our formulations” says Bifodan CEO, Mr. Steen Andersen and continues: ‘We are confident that this unique formulation will meet a demand in the market for nutritional supplements aimed at immune health, and contribute to improved quality of life for the end-user.
